Medical marketing has skyrocketed in the past two decades, while oversight remains limited

(The Dartmouth Institute for Health Policy & Clinical Practice) In an article recently published in the Journal of American Medical Association (JAMA), researchers from The Dartmouth Institute for Health Policy and Clinical Practice reviewed medical marketing (the marketing of prescription drugs, disease awareness, laboratory tests and health services to consumers and professionals) over a 20-year period from 1997 through 2016 and found that while it had increased dramatically from about $17.7 billion to $29.9 billion, regulation has not.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2RA4v7j